57
views
0
recommends
+1 Recommend
1 collections
    3
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Systematic analysis of the metabolites of Angelol B by UPLC-Q-TOF-MS after oral administration to rats

      , , , , ,
      Chinese Journal of Natural Medicines
      Elsevier BV

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Angelicae Pubescentis Radix (APR), a widely used traditional Chinese medicine (TCM), is mainly used to treat rheumatism and headache diseases. Angelol B is one of the bioactive constituents of APR with significant anti-inflammatory activity. This paper is aimed to illustrate the metabolites of angelol B in vivo . To achieve this objective, a metabolomics approach based on a rapid and accurate UPLC-Q-TOF-MS method was used to detect the metabolites of Angelol B in rat. A gradient elution system (ACN and 0.1% formic acid water) equipped with an Agilent SB-C 18 column (1.8 μm, 2.1 mm × 50 mm) to complete the separation. Scanning area at m/z 100−800 operated on an electrospray ionization (ESI). The data were collected in both positive and negative ion mode and analyzed by the Masslynx 4.1 and SIMCA 13.0 software. A total of 31 metabolites including 20 phase І and 11 phase ІІ metabolites were identified. Their structure and fragmentation process were deduced based on the MS and MS/MS data. All of thirty-one metabolites are new compounds based on the search of SCI-Finder database.

          Author and article information

          Journal
          Chinese Journal of Natural Medicines
          Chinese Journal of Natural Medicines
          Elsevier BV
          18755364
          November 2019
          November 2019
          : 17
          : 11
          : 822-834
          Article
          10.1016/S1875-5364(19)30100-1
          ee446aa7-05ee-46b9-9635-03a85211f8fb
          © 2019

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article